We are live on
!
Find out more
HCM
Highbridge Capital Management Portfolio holdings
AUM
$3.09B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+31.19%
3 Year Est. Return
+54.53%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.39%
AUM
$8.22B
AUM Growth
+$272M
(+3.4%)
Cap. Flow
-$981M
Cap. Flow
% of AUM
-11.94%
Top 10 Holdings %
Top 10 Hldgs %
21.98%
Holding
1,489
New
477
Increased
218
Reduced
244
Closed
468
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$57.9M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$52.4M |
| 3 |
ExxonMobil
XOM
|
+$49M |
| 4 |
Colgate-Palmolive
CL
|
+$45.4M |
| 5 |
CF Industries
CF
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$64.1M |
| 2 |
Meta Platforms (Facebook)
META
|
+$58.9M |
| 3 |
MON
Monsanto Co
MON
|
+$54.7M |
| 4 |
CELG
Celgene Corp
CELG
|
+$53.6M |
| 5 |
Target
TGT
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 9.92% |
| 2 | Healthcare | 9.35% |
| 3 | Technology | 6.84% |
| 4 | Consumer Discretionary | 5.39% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Erie Indemnity
ERIE
$12.7B
| – | – |
-5,701
| Closed | -$398K |
|
1052
CALL
Evercore
EVR
$12.4B
| – | – |
-4,800
| Closed | -$265K |
|
|
1053
PUT
Evercore
EVR
$12.4B
| – | – |
-5,200
| Closed | -$287K |
|
1054
EXL Service
EXLS
$5.14B
| – | – |
-186,330
| Closed | -$1.15M |
|
1055
First Bancorp
FBP
$4.42B
| – | – |
-50,619
| Closed | -$275K |
|
1056
First Citizens BancShares
FCNCA
$24.9B
| – | – |
-4,761
| Closed | -$1.15M |
|
1057
Freeport-McMoran
FCX
$90B
| – | – |
-64,743
| Closed | -$2.14M |
|
1058
CALL
FedEx
FDX
$72.7B
| – | – |
-5,200
| Closed | -$690K |
|
|
1059
PUT
FedEx
FDX
$72.7B
| – | – |
-3,400
| Closed | -$451K |
|
1060
FirstEnergy
FE
$28B
| – | – |
-1,501,661
| Closed | -$51.1M |
|
1061
CALL
Five Below
FIVE
$12B
| – | – |
-26,900
| Closed | -$1.14M |
|
|
1062
PUT
Five Below
FIVE
$12B
| – | – |
-27,300
| Closed | -$1.16M |
|
1063
CALL
Flowserve
FLS
$9.71B
| – | – |
-3,200
| Closed | -$251K |
|
|
1064
Flowserve
FLS
$9.71B
| – | – |
-12,145
| Closed | -$921K |
|
1065
Fidelity National Financial
FNF
$13.9B
| – | – |
-126,385
| Closed | -$2.27M |
|
1066
First Solar
FSLR
$22.7B
| – | – |
-3,633
| Closed | -$254K |
|
1067
Federal Signal
FSS
$7.63B
| – | – |
-68,689
| Closed | -$1.02M |
|
1068
Forward Air
FWRD
$444M
| – | – |
-62,927
| Closed | -$2.9M |
|
1069
Galectin Therapeutics
GALT
$196M
| – | – |
-30,973
| Closed | -$474K |
|
1070
Green Dot
GDOT
$743M
| – | – |
-16,119
| Closed | -$315K |
|
1071
CALL
Gen Digital
GEN
$16.4B
| – | – |
-111,700
| Closed | -$2.23M |
|
|
1072
PUT
Gen Digital
GEN
$16.4B
| – | – |
-134,300
| Closed | -$2.68M |
|
1073
Gerdau
GGB
$9.74B
| – | – |
-183,447
| Closed | -$933K |
|
1074
CALL
Gilead Sciences
GILD
$162B
| – | – |
-5,500
| Closed | -$390K |
|
|
1075
PUT
Gilead Sciences
GILD
$162B
| – | – |
-5,000
| Closed | -$354K |
|
Similar funds
DCM
CAM
VBA
MRCP
ECP
TCG
PC
CCI
Highbridge Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Highbridge Capital Management held 1,489 positions worth $8.22B, up 3.4% from $7.94B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Highbridge Capital Management withdrew a net $981M in Q2 2014, closing 468 positions and reducing 244 holdings. Its most notable exit was Celgene Corp, an estimated $53.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 9.9% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Highbridge Capital Management opened a new position in Bausch Health worth $38.6M.
- Highbridge Capital Management's largest Q2 2014 buy was Bausch Health: 305,899 shares worth $38.6M.
- Highbridge Capital Management added most to Citigroup in Q2 2014, an estimated $57.9M increase.
- Highbridge Capital Management's biggest Q2 2014 reduction was Intel, cutting an estimated $64.1M.
- Highbridge Capital Management fully exited Celgene Corp in Q2 2014, selling an estimated $53.6M.
- Highbridge Capital Management's ten largest holdings make up 22% of its $8.22B portfolio in Q2 2014.
- Highbridge Capital Management opened 477 new positions and closed 468 in Q2 2014.
- Highbridge Capital Management's portfolio value rose 3.4% quarter-over-quarter to $8.22B.
Based on Highbridge Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.